Prophylaxis with anti-HBV agent significantly decreased the risk of hepatitis B reactivation.Chien-YuanChenSheng-YiHuangAristineChengWen-ChienChouMingYaoEBSCO_AspPloS oneChen CY, Huang SY, Cheng A et al (2015) High risk of hepatitis B reactivation among patients with acute myeloid leukemia. PLoS ...
Uspstf: Screen High-Risk Patients for Hepatitis BMoon, Mary
Hepatitis B vaccination among high-risk adolescents and adults -- San Diego, California, 1998-2001 MMWR: Morbidity & Mortality Weekly ReportUnited States Department of Health and Human Services. Centers for Disease Control and Prevention
High risk of occult hepatitis B virus infection in leukemia patients from ChinaLeukemia PatientLeukemia GroupStop Codon MutationOccult HepatitisMajor Hydrophilic RegionIn this study, we assessed the prevalence of overt and occult hepatitis B virus (HBV) infection among leukemia patients. Among 256 ...
HEPATITIS B virusSURGEONSDISEASESPresents an abstract of the article 'Hepatitis B Virus Transmission From a Surgeon to Patients During High-Risk As Well As Low-Risk Procedures: Unnoticed Transmissions Over a 4-Year Period,' by I.J.B. Spijkerman, l.J. van ...
China is currently experiencing one of the most rapidly expanding HIV epidemics in the world. Although the overall prevalence rate is still low, with a population of 1.3 billion, high-risk factors which have contributed to the HIV/AIDS epidemics worldwid
Fulminant hepatitis B in infants born to anti-HBe hepatitis B carrier mothers. Infants whose mothers are carriers of hepatitis B and have developed antibodies to the e antigen of the hepatitis B virus (anti-HBe) may be at risk for dev... SV Beath,EH Boxall,RM Watson,... - Bmj 被引...
Families were unaware of the risk of HBV infection and feared vaccination. Aversion to subjecting an infant to pain was a principal reason for failure to complete the study, and frequent contacts were required to ensure adherence. Existence of a safe and effective hepatitis B vaccine and ...
development suggesting the need of more stringent measures for prevention of HCV transmission with implementation of education programs identifying risk factors associated with inappropriate therapeutic modalities, periodic HCV screening and hepatitis B vaccination with booster inoculations to previously vaccinated...
Although there is an effective vaccine for hepatitis B and public health officials have a strong sense of who is at highest risk for the infectious liver disease, tens of thousands of people in the United States contract the virus every year. According t